Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Hanna

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Brain Sciences|July 27, 2024
Dopamine Dysregulation in Reward and Autism Spectrum DisorderKenneth Blum, Abdalla Bowirrat, Keerthy Sunder, et al.
Frontiers in Public Health|May 16, 2025
Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative reviewColin Hanna, Fiona Comstock, Shtakshe Chatrath, et al.
Journal of Personalized Medicine|May 25, 2024
Selenoprotein P in a Rodent Model of Exercise; Theorizing Its Interaction with Brain Reward Dysregulation, Addictive Behavior, and AgingPatrick Mohr, Colin Hanna, Aidan Powell, et al.
Journal of Personalized Medicine|July 29, 2023
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical ResearchPanayotis K Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
Journal of Integrative Neuroscience|July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social BehaviorMichael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences|August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependenceMark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Psychology Research and Behavior Management|February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case SeriesKeerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry|August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Journal of Addiction Psychiatry|December 2, 2024
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 AnalogsEdward Justin Modestino, Abdalla Bowirrat, David Baron, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Brain Sciences|July 27, 2024
Dopamine Dysregulation in Reward and Autism Spectrum DisorderKenneth Blum, Abdalla Bowirrat, Keerthy Sunder, et al.
Frontiers in Public Health|May 16, 2025
Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative reviewColin Hanna, Fiona Comstock, Shtakshe Chatrath, et al.
Journal of Personalized Medicine|May 25, 2024
Selenoprotein P in a Rodent Model of Exercise; Theorizing Its Interaction with Brain Reward Dysregulation, Addictive Behavior, and AgingPatrick Mohr, Colin Hanna, Aidan Powell, et al.
Journal of Personalized Medicine|July 29, 2023
The First Exploratory Personalized Medicine Approach to Improve Bariatric Surgery Outcomes Utilizing Psychosocial and Genetic Risk Assessments: Encouraging Clinical ResearchPanayotis K Thanos, Colin Hanna, Abrianna Mihalkovic, et al.
Journal of Integrative Neuroscience|July 4, 2025
Exercise Leads to Brain Glucose Metabolism Activation, Increased Dopamine D1 Receptor Levels and is Negatively Correlated with Social BehaviorMichael Bobick, Colin Hanna, John Tyler, et al.
INNOSC Theranostics & Pharmacological Sciences|August 9, 2024
A historical perspective on clonidine as an alpha-2A receptor agonist in the treatment of addictive behaviors: Focus on opioid dependenceMark S Gold, Kenneth Blum, Abdalla Bowirrat, et al.
Psychology Research and Behavior Management|February 6, 2025
Coupling Bio-Resonance Neurotechnology (BRNT) and Dual Hemispheric Repetitive Transcranial Magnetic Stimulation (rTMS) Reduces Comorbid Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) as Demonstrated by PHQ-9 and GAD-7: Pilot Case SeriesKeerthy Sunder, Milan T Makale, Miles Makale, et al.
Journal of Addiction Psychiatry|August 10, 2023
Psychostimulants for Children: Are We Over or Under Dosing?Kenneth Blum, Catherine Dennen, Paul R Carney, et al.
Clinical and Experimental Psychology|August 10, 2023
Evidence for the <i>DRD2</i> Gene as a Determinant of Reward Deficiency Syndrome (RDS)Kenneth Blum, Abdala Bowirrat, Igor Elman, et al.
Journal of Addiction Psychiatry|December 2, 2024
Is There a Natural, Non-addictive, and Non-anti-reward, Safe, Gene-based Solution to Treat Reward Deficiency Syndrome? KB220 Variants vs GLP-1 AnalogsEdward Justin Modestino, Abdalla Bowirrat, David Baron, et al.
Pageof 4